Valeant, Savaria out with figures, hit 52-week highs

Valeant Pharmaceuticals International, Inc. (T.VRX) hit a new 52-week high of $99.59 Wednesday. Valeant Pharmaceuticals announces second quarter financial results for 2013. Valeant's total revenues were $1.1 billion, up 34% compared to the second quarter of 2012, and product revenues were $1.06 billion, up 43% versus the year-ago quarter.

The Company reported net income of $11 million for the second quarter of 2013, or $0.03 per diluted share. On a Cash EPS basis, adjusted income was $421 million, or $1.34 per diluted share.

Savaria Corporation (T.SIS) hit a new 52-week high of $2.01 Wednesday. Savaria Corporation today announced its results for the second quarter ended June 30, 2013. Revenue for the second quarter is up 11% from $17.5 million in 2012 to $19.4 million in 2013.

This is the highest quarterly revenue in the Corporation's history. Net income for the second quarter is up 106% or $734,000, from $691,000 in 2012 to $1.4 million in 2013

Aastra Technologies Limited (T.AAH) hit a new 52-week high of $26.42 Wednesday. No news announcements today.

Equal Energy Ltd. (T.EQU) hit a new 52-week high of $4.67 Wednesday. No news announcements today.

ClubLink Enterprises Limited (T.CLK) hit a new 52-week high of $9.80 Wednesday. No news announcements today.

Exco Technologies Limited (T.XTC) hit a new 52-week high of $6.70 Wednesday. No news announcements today.

Klondex Mines Ltd. (T.KDX) hit a new 52-week high of $1.61 Wednesday. No news announcements today.


Related Stories